Form 4: Marimed CFO Mario Pinho Reports RSU Vesting and Tax-Related Share Disposition
Insider Transaction Report
Marimed Inc.'s Chief Financial Officer, Mario Pinho, reported the vesting of 16,075 Restricted Stock Units (RSUs) into common stock and the subsequent disposition of 5,571 shares to cover tax withholding obligations.
Summary
- Mario Pinho, Chief Financial Officer of Marimed Inc. (MRMD), reported transactions related to his beneficial ownership.
- On June 15, 2025, 16,075 Restricted Stock Units (RSUs) vested and converted into an equal number of common stock shares.
- Concurrently, 5,571 shares of common stock were disposed of at a price of $0.0725 per share to satisfy tax withholding obligations associated with the RSU vesting.
- Following these transactions, Mr. Pinho directly beneficially owns 45,513 shares of common stock.
- Additionally, Mr. Pinho holds 32,171 unvested Restricted Stock Units.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction (RSU vesting and tax-related sale) which is a neutral event and does not indicate significant positive or negative sentiment regarding the company's performance or outlook.
Positives
- The vesting of RSUs indicates the fulfillment of compensation agreements, aligning management's interests with shareholders.
Negatives
- The disposition of 5,571 shares to cover tax obligations reduces the direct common stock holdings of the CFO.
Future Outlook
The remaining 32,171 Restricted Stock Units held by Mario Pinho are scheduled to vest in two equal installments on September 15, 2025, and December 15, 2025.
Industry Context
This filing represents a routine insider transaction related to executive compensation, which is a common practice across various industries, including the cannabis sector where Marimed operates. Such transactions are standard mechanisms for employee retention and incentive alignment.
Related Party Transactions
- The vesting of Restricted Stock Units and subsequent share disposition for tax purposes constitutes a transaction between the company (Marimed Inc.) and its Chief Financial Officer, Mario Pinho, which is a common form of related party compensation arrangement.
Stakeholder Impact
- Shareholders: The disposition of shares for tax purposes slightly reduces the direct ownership stake of a key executive, but the overall transaction is a standard part of executive compensation.
- Employees: The RSU vesting demonstrates the company's commitment to its compensation plans, which can positively impact employee morale and retention.
Next Steps
- Remaining Restricted Stock Units (RSUs) held by Mario Pinho will vest in two equal installments on September 15, 2025.
- Remaining Restricted Stock Units (RSUs) held by Mario Pinho will vest in two equal installments on December 15, 2025.
Key Dates
| Date | Description |
|---|---|
| 05/09/2025 | Date RSUs were granted to Mario Pinho. |
| 06/15/2025 | Date of RSU vesting and related common stock transactions for Mario Pinho. |
| 06/16/2025 | Date the Form 4 filing was signed by Mario Pinho. |
| 09/15/2025 | First future vesting date for remaining RSUs held by Mario Pinho. |
| 12/15/2025 | Second future vesting date for remaining RSUs held by Mario Pinho. |
Keywords
Marimed Inc., MRMD, Mario Pinho, Chief Financial Officer, CFO, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Stock Vesting, Share Disposition, Tax Withholding, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.